CME Group (NASDAQ:CME) Receives "Neutral" Rating from UBS Group

CME Group (NASDAQ:CME - Get Free Report)'s stock had its "neutral" rating restated by analysts at UBS Group in a research report issued on Thursday, MarketBeat.com reports. They currently have a $305.00 price objective on the financial services provider's stock. UBS Group's target price would suggest a potential upside of 9.99% from the company's current price.

CME has been the topic of several other reports. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Barclays increased their price target on shares of CME Group from $283.00 to $299.00 and gave the company an "equal weight" rating in a report on Thursday, July 10th. Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Piper Sandler raised their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Finally, Keefe, Bruyette & Woods raised their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $261.73.

CME Group Stock Up 0.3%

Shares of CME Group stock traded up $0.82 during trading hours on Thursday, reaching $277.30. 936,676 shares of the company's stock were exchanged, compared to its average volume of 2,376,391. The company has a 50 day moving average of $276.31 and a two-hundred day moving average of $261.54. CME Group has a fifty-two week low of $193.25 and a fifty-two week high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $99.93 billion, a P/E ratio of 27.89, a P/E/G ratio of 4.79 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. CME Group's revenue was up 10.4% on a year-over-year basis. During the same period last year, the business posted $2.56 EPS. On average, sell-side analysts forecast that CME Group will post 10.49 EPS for the current fiscal year.

Insider Activity at CME Group

In related news, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $277.88, for a total value of $294,552.80. Following the transaction, the director owned 3,108 shares in the company, valued at $863,651.04. The trade was a 25.43% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the sale, the director directly owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,400 shares of company stock valued at $3,152,410 in the last quarter. Insiders own 0.30% of the company's stock.

Institutional Investors Weigh In On CME Group

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Wayfinding Financial LLC bought a new stake in shares of CME Group during the first quarter worth about $25,000. Webster Bank N. A. grew its position in CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after purchasing an additional 60 shares in the last quarter. Cornerstone Planning Group LLC grew its position in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Highline Wealth Partners LLC boosted its stake in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 43 shares during the last quarter. Finally, New Age Alpha Advisors LLC boosted its stake in CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 43 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.